ATLASABVC Biopharma (ABVC) earnings date: expected May 9–15
ABVC Biopharma (ABVC) has not announced its next earnings date yet. Based on its last 4 reports, ATLAS expects it around May 9–15. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ABVC
| Last price | $1.00 (-3.9%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.4% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 4 reports |
These figures come from the same calibrated model and valuation as the ABVC Biopharma stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around May 9–15 (estimate). One email the day before, with ATLAS’s read on ABVC Biopharma. You can switch it off at any time.
Alert me before ABVC reportsFree to start. Creating an account takes under a minute.
ABVC earnings at a glance
| Next report | Not announced · expected around May 9–15 (ATLAS estimate) |
|---|---|
| Last report | Oct 30, 2026 |
| Beat rate (last 4 reports) | 3 of 4 (75%) |
| Average EPS surprise | +10.2% |
| Average move around a report | ±7.1% (last 4) |
| Sector | Healthcare · Biotechnology |
The expected window is an ATLAS estimate: it takes the typical gap between ABVC Biopharma’s last 4 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
ABVC Biopharma earnings history: last 5 reports
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 30, 2026 | – | -$0.05 | – | – | – |
| Jul 29, 2026 | $1.19 | $1.35 | +13.5% | Beat | +1.9% |
| Jan 16, 2026 | $4.47 | $4.67 | +4.5% | Beat | +4.9% |
| Jan 8, 2026 | $0.07 | $0.10 | +42.9% | Beat | -5.6% |
| May 14, 2023 | -$0.05 | -$0.06 | -20.0% | Miss | -16.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ABVC
See the fair value, the probability range and the earnings history of ABVC Biopharma on its ATLAS page.
ABVC Biopharma (ABVC) stock analysisPlans from €3.99 a month.
ABVC Biopharma earnings: frequently asked questions
When is ABVC Biopharma (ABVC) next earnings date?
ABVC Biopharma has not announced its next report. Its last 4 reports came Oct 30, 2026, Jul 29, 2026, Jan 16, 2026, May 14, 2023, so ATLAS estimates the next one around May 9–15. This is an estimate based on that pattern, not a confirmed date.
How often does ABVC beat earnings estimates?
Of its last 4 reports with a recorded result, ABVC Biopharma beat the EPS estimate 3 times; the average surprise was +10.2%. Past results do not predict the next one.
How much does ABVC move around earnings?
Over its last 4 reports the stock moved an average of 7.1% (absolute, from the close before the report day to the close after it), and finished higher 2 of 4 times.
How much does ABVC usually move in a day?
On a normal trading day the ATLAS model puts ABVC’s one-day range at about ±4.4%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer